2m 2m 2m 2m 2m 2m 2m
DELCATH SYS (DCTH)
NASDAQ
$10.21-$0.32 (-3.09%)
Price as of Jun 03, 2026 6:52 PM EDT- $372.1MMarket Cap
- -34.51%1-Year Change
- Medical DevicesIndustry
DELCATH SYS (DCTH)
$10.21-$0.32 (-3.09%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 85.2M +129.08% | 37.2M +1,701.69% | 2.1M -24.05% | 2.7M -23.52% | |
Cost of Revenue | 11.8M +90.64% | 6.2M +874.49% | 635,000 -7.43% | 686,000 +2.24% | |
Gross Profit | 73.4M +136.75% | 31.0M +2,069.02% | 1.4M -29.66% | 2.0M -29.51% | |
Sales and Marketing Expense | 43.5M +47.29% | 29.6M +33.66% | 22.1M +27.78% | 17.3M +26.88% | |
Research and Development Expense | -29.2M +110.80% | -13.9M -20.73% | -17.5M -5.82% | -18.6M +34.87% | |
Depreciation and Amortization Expense | 238,000 +77.61% | 134,000 +4.69% | 128,000 -3.03% | 132,000 -9.59% | |
Total Operating Expenses | 72.8M +67.58% | 43.4M +9.63% | 39.6M +10.38% | 35.9M +30.90% | |
Operating Profit | 660,000 +105.32% | -12.4M -67.50% | -38.2M +12.79% | -33.9M +38.00% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.4M -46.41% | -2.7M +126.39% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -1.4M -46.41% | -2.7M +126.39% | |
Total Nonoperating Income and Expense | -70,000 +133.33% | -30,000 -49.15% | -59,000 -296.67% | 30,000 -55.88% | |
Income before Taxes | 3.5M +128.28% | -12.4M -67.50% | -38.2M +12.79% | -33.9M +31.99% | |
Income Taxes | 810,000 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 2.7M +110.23% | -26.4M -44.66% | -47.7M +30.60% | -36.5M +42.34% | |
Net Income from Continuing Operations Applicable to Common | 3.5M +113.30% | -26.4M -44.66% | -47.7M +30.60% | -36.5M +42.34% | |
Basic EPS and Net Income | 0.08 +108.60% | -0.93 -68.37% | -2.94 -28.64% | -4.12 +14.76% | |
Diluted EPS and Net Income | 0.07 +107.53% | -0.93 -68.37% | -2.94 -28.64% | -4.12 +14.76% | |
Basic Weighted Average Shares | 35.8M +25.64% | 28.5M +75.67% | 16.2M +83.09% | 8.9M +24.05% | |
Diluted Weighted Average Shares | 39.9M +40.01% | 28.5M +75.67% | 16.2M +83.09% | 8.9M +24.05% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 43.5M +34.07% | 32.4M +156.30% | 12.6M +64.85% | 7.7M -66.36% | |
Short-Term Investments | 47.6M +128.53% | 20.8M +5.11% | 19.8M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 91.0M +71.01% | 53.2M +64.03% | 32.5M +323.07% | 7.7M -66.36% | |
Total Current Assets | 119.5M +62.05% | 73.8M +98.50% | 37.2M +130.01% | 16.2M -48.14% | |
Accumulated Depreciation | 5.2M +5.93% | 5.0M -2.38% | 5.1M +2.92% | 4.9M +2.20% | |
Property and Plant and Equipment and Net | 3.2M +76.87% | 1.8M +32.40% | 1.4M -4.92% | 1.4M +5.49% | |
Total Long-Term Assets | 3.2M +76.87% | 1.8M +32.40% | 1.4M -4.92% | 1.4M +5.49% | |
Total Assets | 123.6M +61.42% | 76.6M +98.35% | 38.6M +116.17% | 17.9M -46.08% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 10.2M +29.37% | 7.8M +199.35% | |
Total Current Liabilities | 10.9M +78.22% | 6.1M -62.65% | 16.4M +11.63% | 14.7M +147.48% | |
Total Long-Term Debt | N/A N/A | 0 N/A | 0 -100.00% | 7.8M -47.76% | |
Total Long-Term Liabilities | 628,000 -18.02% | 766,000 -8.81% | 840,000 -26.57% | 1.1M -49.80% | |
Total Liabilities | 12.4M +58.27% | 7.8M -65.66% | 22.8M -3.73% | 23.7M +12.04% | |
Retained Earnings | -528.8M -0.51% | -531.5M +5.22% | -505.2M +10.42% | -457.5M +8.67% | |
Total Stockholders Equity | 111.2M +61.78% | 68.7M +335.74% | 15.8M +369.28% | -5.9M -149.02% | |
Total Shares Outstanding | 34.7M +4.93% | 33.1M +45.25% | 22.8M +187.88% | 7.9M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 22.5M +220.53% | -18.7M -40.22% | -31.3M +25.25% | -24.9M +10.38% | |
Capital Expenditures | 1.5M +176.74% | 559,000 +863.79% | 58,000 -72.25% | 209,000 +46.15% | |
Cash from Investing Activities | -26.6M +2,610.50% | -981,000 -95.02% | -19.7M +9,330.14% | -209,000 +46.15% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 15.0M -61.82% | 39.4M -23.89% | 51.8M +410.48% | 10.1M -51.29% | |
Financials Ratio | |||||
Gross Margin | 86.16% +3.35% | 83.37% +20.39% | 69.25% -7.38% | 74.77% -7.83% | |
Operating Margin | 0.77% +102.32% | -33.36% -98.20% | -1,849.01% +48.51% | -1,245.05% +80.43% | |
Return on Assets | 2.70% +105.89% | -45.81% -72.87% | -168.85% +17.90% | -143.21% +89.16% | |
Return on Equity | 3.00% +104.81% | -62.44% -93.51% | -961.44% -19.77% | -1,198.36% +694.97% | |
Revenue Growth | 129.08% -92.41% | 1,701.69% +7,174.77% | -24.05% +2.28% | -23.52% -120.28% | |
Current Ratio | 10.92 -9.07% | 12.01 +431.42% | 2.26 +106.05% | 1.10 -79.04% | |
Cash Ratio | 3.97 -24.78% | 5.28 +586.19% | 0.77 +47.68% | 0.52 -86.41% | |
Debt-to-Equity Ratio | N/A N/A | 0.00 -100.00% | 0.64 +124.03% | -2.68 -281.51% | |
Debt-to-Assets Ratio | N/A N/A | 0.00 -100.00% | 0.26 -70.07% | 0.88 +65.00% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow